Product
Placebo for Topiramate
1 clinical trial
1 indication
Indication
MigraineClinical trial
A Randomized, Double-Blind, Parallel-Group, Active Controlled Trial With Open-Label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)Status: Recruiting, Estimated PCD: 2026-06-14